Coronary Calcium Scoring and Risk Assessment



Similar documents
Will The Coronary Calcium Score Affect the Decision To Treat With Statins?

Main Effect of Screening for Coronary Artery Disease Using CT

FFR CT : Clinical studies

MYOCARDIAL PERFUSION COMPUTED TOMOGRAPHY PhD course in Medical Imaging. Anne Günther Department of Radiology OUS Rikshospitalet

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Efficient Evaluation of Chest Pain

For the NXT Investigators

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Listen to your heart: Good Cardiovascular Health for Life

Q1: Global risk assessment using PROCAM, SCORE, FRAMINGHAM or REYNOLDS ecc is sufficient YES NO NEED MORE DATA DISCUSS within Taskforce Your Comments

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

Atherosclerosis of the aorta. Artur Evangelista

Coronary Heart Disease (CHD) Brief

Perioperative Cardiac Evaluation

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

Prognostic impact of uric acid in patients with stable coronary artery disease

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity

Section 8: Clinical Exercise Testing. a maximal GXT?

Cilostazol versus Clopidogrel after Coronary Stenting

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

MDCT Technology. Kalpana M. Kanal, Ph.D., DABR Assistant Professor Department of Radiology University of Washington Seattle, Washington

Predictive value of clinical risk assessment tools and guidelines for 10-year coronary heart disease risk in practice-based primary care

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Evidence-Based ACC/AHA Guidelines for Cardiovascular Risk Assessment

Fewer people with coronary heart disease are being diagnosed as compared to the expected figures.

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine

State-of-the-Art Technology in Cardiac CT

Noninvasive testing can provide useful information for

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

Vascular Quality Initiative - Carotid Artery Stent. Last Name First Name Middle Initial

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

Acute Coronary Syndrome. What Every Healthcare Professional Needs To Know

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Cardiovascular Endpoints

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Cardiovascular Endpoints

Hormone Replacement Therapy : The New Debate. Susan T. Hingle, M.D.

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs

Non-invasive FFR Using Coronary CT Angiography and Computational Fluid Dynamics Predicts the Hemodynamic Significance of Coronary Lesions

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators

Purchasing a cardiac CT scanner: What the radiologist needs to know

Non-invasive functional testing in 2014

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Pre-Operative Cardiac Evaluation Kalpana Jain, MD

Predictive Implications of Stress Testing (Chapt. 14) 1979, Weiner and coworkers. Factors to improve the accuracy of stress testing

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

MEDICAL BREAKTHROUGHS RESEARCH SUMMARY TOPIC: MAMMOGRAM FOR THE HEART: CORONARY CALCIUM SCORE REPORT: MB #4014

Cardiovascular Disease in Diabetes

Imaging of Thoracic Endovascular Stent-Grafts

Majestic Trial 12 Month Results

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

EMR Tutorial Acute Coronary Syndrome

Summary Evaluation of the Medicare Lifestyle Modification Program Demonstration and the Medicare Cardiac Rehabilitation Benefit

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Cardiac CT for Calcium Scoring

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

African Americans & Cardiovascular Diseases

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery

Utilization Review Cardiac Rehabilitation Services: Underutilized

06 Validation of risk prediction model

Coronary Bifurcation Treatment: Update from the European Bifurcation Club. Remo Albiero, MD Ist. Clinico S. Rocco Brescia (Italy)

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease. Erich Minar Medical University Vienna

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?

What is a Heart Attack? 1,2,3

Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study

Acquired Heart Disease: Prevention and Treatment

None. Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management. 76 year old male LINGO 1/5/2015

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Cardiac Rehabilitation CARDIAC REHABILITATION HS-091. Policy Number: HS-091. Original Effective Date: 3/16/2009

All patients presenting to the Emergency Department with symptoms suggestive of

LEADERS: 5-Year Follow-up

Master s Program in Medical Physics. Physics of Imaging Systems Basic Principles of Computer Tomography (CT) III. Prof. Dr. Lothar Schad.

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November :38

ECG may be indicated for patients with cardiovascular risk factors

Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC

JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014

Aortic Valve Stenosis and CAD

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

Malmö Preventive Project. Cardiovascular Endpoints

Perioperative management of Dual Antiplatelet therapy post drug eluting stent-changing time

Impact of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care

Transcription:

Norbert Wilke, MD, F.A.C.C., F.E.S.C. Associate Professor of Radiology Associate Professor of Medicine Courtesy to Franz von Ziegler, MD Univ. of Munich, Germany Coronary Calcium Scoring and Risk Assessment

Why Do We Need New Tests? Coronary Heart Disease (CHD): No. 1 Killer! > 50% of death in diabetic patients due to CHD No prior diagnosis! primary manifestation of CHD: No prior - 55% Angina pectoris clinical - 25% myocardial infarction symptoms!!! - 20% sudden coronary death Goal: risk stratification and detection of CHD before (!) it causes symptoms

Calcium is just a surrogate marker for coronary artery disease, isn't it? Calcified plaque is an American Heart Association (AHA) type Vb atheroma that takes an individual from having risk factors for atherosclerosis to having documented disease!

Risk Factors (Vogel et al. Rev Cardiovasc Med. 2000)

PROCAM Score age (years) 35-39 0 40-44 6 45-49 11 50-54 16 55-59 21 60-65 26 LDL-Cholesterin (mg/dl) systolic RR (mm Hg) <120 0 120-129 2 130-139 3 140-159 5 >=160 8 HDL-Cholesterin (mg/dl) Estimated risk of cardiovascular events within 10 <100 0 <35 11 100-129 5 years: 35-44 8 130-159 10 45-54 5 < 160-189 10% = 14 low risk >54 0 >189 20 10% Diabetes - 20% = intermediate Smoking risk no 0 no 0 > yes 20% = high 6 risk yes 8

Diagnostic Threshold Comparison to Framingham- and PROCAM-Score Diagnostic threshold: 1,0 P < 0.05 Framinghamscore 0,63 Procamscore 0,65 Volumescore 0,81 Sensitivity 0,5 ROC-Curve Prediction of MI 0,5 1,0 1-Specificity Becker A, Knez A et al. Circulation 2004 (Suppl)

Current Non Invasive Diagnostic Tests EKG Treadmill Echocardiography

Invasive vs. Non-invasive Modalities non-invasive Stress EKG Stress Echo SPECT PET Coronary CT Calcium Screening invasive IVUS Cath 0% 20% 45% 60% 70% 90% normal II-III IV Va Vb Vc Erbel et al., HERZ 1996

Cardiac Computed Tomography Coronary Calcium Scoring Coronary Angiography prognostic value coronary stenosis progression of atherosclerosis plaque burden coronary stenosis detection angiography of bypasses plaque imaging coronary stents

Coronary Calcium Scoring (CS) http://cardiacimaging.ufl.edu/training/ www.cctaboardreview.com

Coronary Calcium Scoring

Coronary Calcium Scoring Berechnungsoberfläche Aortenkalk

Agatston-Score Calcified Plaquearea [mm²] CT-Numbers depending on plaquedensity X 130-200 HU = # 1 201-300 HU = # 2 301-400 HU = # 3 > 400 HU = # 4 high variability reduced reproducebility depends on slice thickness

Volume Score and Calcium Mass Volume Score = isotropic interpolation between axial slices - 3-dimensional modality - independent of slicethickness - lower interscan-variability, than Agatstonscore Calcium Mass = callibration with calcium standard mass - 3-dimensional modality - theoretically no interscan-variability (multicenter-trials with different scanners)

ELECTRON BEAM CT(EBCT)

COMPARISON OF CALCIUM SCORES WITH EBCT V MDCT Detrano et al. Radiology 2005;236:477-84. 6814 pts (MESA) scanned by EBCT & MDCT Agatston scores, calcium volumes, & interpolated volumes measured Agreement between EBCT & MDCT was 96% in detecting coronary artery calcification Motion & misregistration artifacts more prevalent with MDCT Noise artifacts more common with EBCT Volume-based scores slightly more reproducible with either technology In general, Ca scoring can be performed with equivalent reproducibiltiy with EBCT or MDCT scanning & reading protocols are standardized Overlapping image sections, shorter triggering intervals, & using volume scores are all steps that may lead to increased reproducibilty (were not done in MESA)

Volume score: Correlation between EBCT and MSCT 10,00 EBCT ln (volume score+1) 8,00 6,00 4,00 2,00 n = 367 r = 0.84 EBCT: 345 402 MSCT: 362 478 0,00 0,00 2,00 4,00 6,00 8,00 10,00 MSCT ln(volume score +1) p = 0.34

Coronary Calcium Scan Protocol tube voltage: 120 kv tube current: 200 mas (4D care dose on) collimation: 30 x 0.6 slice thickness 3.0 mm increment 1.5 axial slices B 36f - Kernel Native Scan No contrast agent Less radiation Quick and easy to handle

TYPES OF CALCIUM QUANTIFICATION Agatston score is nonlinear and sensitive to changes based on a single pixel. Initially designed for EBCT technology (not MDCT). Volume score introduced to improve reproducibility, but does not always represent true volume of calcification. Calcium mass should be more reliable regardless of system and protocol used. Larger studies needed!.

Coronary Calcification and Atherosclerosis non-invasive marker of coronary atherosclerosis sensitive parameter of early stages of disease conventional coronary angiography computed tomography angiography

Normogram CS (Hoff et al Am J Cardiol 2001) men (25,251) years < 40 40-44 45-49 50-54 55-59 60-64 65-69 25. Percentile 0 0 0 1 4 13 32 50. Percentile 0 1 3 15 48 113 180 75. Percentile 3 9 36 103 215 410 566 90. Percentile 14 59 154 332 554 994 1299 women (9,995) years 35-39 40-44 45-49 50-54 55-59 60-64 65-69 25. Percentile 0 0 0 0 0 0 1 50. Percentile 0 0 0 0 1 3 24 75. Percentile 1 1 2 5 23 57 145 90. Percentile 3 4 22 55 121 193 410

Atherosclerosis and coronary artery disease is a condition of middle-age and older adults? Coronary Artery Risk Development in Young Adults (CARDIA): Individuals with a mean age of 45 years (range, 38 to 50 years), 19% had advanced atheromatous coronary artery disease Arteriosclerosis, Thrombosis, and Vascular Biology, January 1991, Vol. 17:1, pp. 51-55 The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Approximately 19% of 30- to 34-year-old men and 8% of 30- to 34-year-old women had atherosclerotic stenosis ± 40% in the LAD Circulation, July 25, 2000, Vol. 102:4, pp. 374-379

Potential of Preventive and Therapeutic Screening: Frequency of Atherosclerosis

Prognostic Value of Coronary Calcification http://cardiacimaging.ufl.edu/training/ www.cctaboardreview.com

Is coronary calcium just debris? Coronary Calcium: It's just stable, burnt-out disease? Is only non-calcified plaque important? The frequency of calcium deposits is significantly different in patients suffering events, the average number of calcium deposits is significantly higher in those with acute myocardial infarction (AMI) compared to those with stable angina (p < 0.0005).

Everyone gets calcified plaque can't we just ignore it in old people? The Rotterdam Coronary Calcification study : N=1,795 older asymptomatic individuals for a mean 3.3 years (mean age, 71 years; range, 62 to 85 years) followed and correlated the incidence of cardiac events with the presence of coronary artery calcification. Circulation, July 26, 2005, Vol. 112:4, pp. 572-577). Vliegenthart and colleagues reported that the relative risk of coronary events was : 3.1% (95% confidence index [CI], 1.2 to 7.9) for calcium scores of 101 to 400, 4.6% (95% CI, 1.8 to 11.8) for calcium scores of 401 to 1000, and 8.3% (95% CI, 3.3 to 21.1) for calcium scores greater than 1000 compared with calcium scores of 0 to 100.

Follow-up Study of asymptomatic individuals n = 1288 (men = 743), timeperiod 4,6 ± 1,8 years 12 12 Event Rate (%/ year) 8 4 8 4 0 0 SCD MI PTCA Stroke plötzlicher Herztod Myokardinfarkt PTCA cerebraler Insult Gruppe I (Score 0) Gruppe II (Score < 100) Gruppe III (Score > 100) Group I: no sudden coronary death (SCD), no myocardial infarction (MI), no PTCA, no stroke Becker A, Knez A et al. Circulation, November 30, 2004, Vol. 110:22, pp. 3424-3429).

Relative risk of future PTCA in dependence of Calcium score: 16 10 12 relative risk 8 4 0,5 0 100 200 300 400 34 Ca score 243 Becker A, Knez A et al. Circulation 2004 (Suppl)

Coronary calcium doesn't work in women and minorities! Multi-Ethnic Study of Atherosclerosis (MESA) : assessed calcium as a predictor of coronary events in four ethnic groups: Whites (38.6%), blacks (27.6%), Chinese Americans (11.9%), and Hispanics (21.9%) ( Adjusted risk of a coronary events: - Increased by 7.73% among participants with calcium scores between 101 and 300 - Increased by 9.67% among those with scores above 300 (p < 0.001 for both comparisons) Among the four racial and ethnic groups, a doubling of the calcium score increased the risk of a major coronary event by 15% to 35% and increased the risk of any coronary events by 18% to 39% The areas under the ROC curves for predicting major coronary events and any coronary event were higher when the calcium score was added to the standard risk factors New England Journal of Medicine, March 27, 2008, Vol. 358:13, pp. 1336-1345).

ASYMPTOMATIC PATIENTS Events Studied 8855 asymptomatic low- moderate-risk pts (30-76yo); Followed for mean 37 months Events: death, MI, revascularization(soft) CA Ca detected in 74% men & 51% women 224 confirmed events during follow-up Association between Ca and all events (except hard events & women) Ca independently associated with cardiac events (RR greater than that of traditional RF s) Kondos et al. Circulation 2003;107:2571-2576.

ASYMPTOMATIC PATIENTS-Prognosis Raggi et al. Am Heart J 2001;141:375-82. Studied 676 asymptomatic pts referred for EBCT 10122 pts screened by EBCT for Ca score nomograms Assessed Ca score in predicting hard events Ca score>0 associated with 3%/yr event rate; 0.12% if 0 Univariate analyses demonstrate that age, smoking, DM, and Ca score predictive of events Multiple logistic regression analyses showed Ca score alone was best predictor of events Ca score added prognostic information to traditional RF s

St. Francis Heart Study n= 4.903 asymptomatic individuals Follow up 4.3 years end points: (A) sudden coronary death, myocardial infarction (B) Bypass-Surgery, PCI (C) Stroke (D) Surgery due to periphareal artery disease Cutoff: Agastonscore 100 70 60 59 50 40 30 40 n=4903 20 10 7 13 0 A B C D Arad et al. JACC 2005

Prognostic value for overall mortality in 10,377 asymptomatic individuals Shaw L et al. Radiology 2003

Ruling out of CHD In the ED! http://cardiacimaging.ufl.edu/training/ www.cctaboardreview.com

CS in 1,764 symptomatic individuals Haberl R, Knez A, et al. JACC 2001

UTILITY OF CA SCORE IN THE EMERGENCY DEPARTMENT Study of 192 pts >30yo presenting to ED with CP & non-diagnostic ECG Average F/U 50+10 months 0.6% annualized event rate for Ca Score 0 13.9% for pts with Ca Score>400 Regression analysis showed Ca Score to be associated with greater risk of CV event independent of age, gender, race, and other RF s Previous studies had limited F/U; This study had 7yr F/U Gergiou et al. JACC 2001;38:105-110

UTILITY OF CA SCORE IN THE EMERGENCY DEPARTMENT May be appropriate in low-to-intermediate risk pts with negative enzymes & equivocal ECG. High sensitivity & negative predictive values NPV for both short(1 month)- & long(7 yr)- follow-up Score of 0 allows for early discharge without admission to floor or observation unit and subsequent stress testing?! Potential to be cost effective if applied to proper patient population /age! More data required!

Progression of Atherosclerosis - Monitoring of Therapy - http://cardiacimaging.ufl.edu/training/ www.cctaboardreview.com

Is the presence of coronary artery calcium Not static and stable? Woman's Health Initiative 1,064 women (mean age 55 years) were randomized to receive estrogen hormone replacement therapy (HRT) or a placebo for a mean 7.4 years of treatment. HRT had a protective effect: -42% reduction in calcified plaque among women randomized to receive HRT - 61% reduction in plaque in those with at least 80% adherence to the study medication New England Journal of Medicine, June 21, 2007, Vol. 356:25, pp. 2591-2602

CS-follow-up after Statin-Therapy Scan 1: 444 mm 3 Scan 2: 428 mm 3 Follow-up 14 months: Statin progression score Scan 1: 444 mm 3 64bpm, 250ms Scan 2: 428mm 3 no therapy 26 % 66bpm, 250ms Cerivastatin (LDL > 130 mg/dl) 9.5 % Cerivastatin (LDL < 100 mg/dl) - 1.0 % Achenbach S et al. Circulation 2002

Calcium and Plaqe burden Progression, Outcome, Regression http://cardiacimaging.ufl.edu/training/ www.cctaboardreview.com

Calcium vs. Plaque No. of calcified coronary segments/pt. Y = -0.67 + (0.90 * X) r = 0.86 p < 0.0001 N = 40 patients total of 222 coronary segments examined No. of coronary segments/pt. with plaques (IVUS) Schmermund et al AJC 1998; 81: 141-146

Conclusion Calcium-Score = 0: low likelihood of significant stenosis high Calcium-Score in asymptomatic patients does not mean high risk of high grade stenosis no cath-lab indication no screening modality for having significant CHD Calcium-Scoring as a prognostic tool better than conventional risk factor assessement high predictive value in case of MI or Coronary Death useful tool for risk assessement in patients of intermediate risk BETTER PROGNOSTIC PREDICTOR THAN AGE!

NEW STUDIES IN PROGRESS OR PUBLISHED Heinz Nixdorf RECALL Study: 4200 pts 45-75yo Prospective study of EBCT, carotid intima-media thickness, ABI, and other RF s in risk assessment for hard CV events MESA Dallas Heart Disease Prevention Project Epidemiology of Coronary Calcification Study in Olmsted County, Minnesota Prospective Army Coronary Calcium Project in Washington, D.C.

Additional References

CS in 1,764 symptomatic individuals Score = O no sign. CHD (> 75%) Sens. Spez. PPV NPV < 60 y Male 99% 32% 48% 98% female 100% 55% 56% 100% > 60 y male 100% 39% 66% 100% female 100% 23% 44% 100% Haberl R, Knez A, et al. JACC 2001

Risk Assessement Good correlation Score / MI based on whole population R = 0.73-0.84 for individual patient: Sensitivity max. 71 % Specificity max. 58 % No efficient therapy possible! AHA Guidelines on Prevention of CAD, 2002

Comparison to Framingham score and Procam score: fraction in patients with myocardial infarction (%) Risk scores of patients with myocardial infarction (n = 73) 100 80 60 40 20 0 83 63 60 27 32 17 10 8 < 10 % 10-20 % > 20 % < 10 % 10-20 % > 20 % > 50. > 75. Framingham score Procam score Percentile Becker A, Knez A et al. Circulation 2004 (Suppl)

CAC in stable vs. unstable disease 2,163 consecutive symptomatic patients 1,354 men, 809 women, age 62.5 ± 10.5 years conventional angiography and calcium screening Yamanaka O et al. Circ J 2002

Plaque burden as assessed by CT-Angiography SAP vs. AMI Leber A et al. Am J Cardiol 2003

CAC as a marker for plaque burden? Histopathologic Correlation: Calcium area was roughly 20% of total plaque area Rumberger et al. Circulation 1995 versus Caussin et al. Am J Cardiol. 2003

Age and Gender Distribution of CS 8 7 6 Ln Score n = 35,246 5 4 männlich weiblich 3 2 1 0 <40 40-44 45-49 50-54 55-59 60-64 65-69 70-74 >74 years Hoff et al. Am J Cardiol 2001

Relative risk of fututre PTCA in dependence of cardiovasular risk factors compared to calcium score: relative risk 8 6 4 n = 142 n = 352 n = 598 n = 312 n = 397 n = 299 * * = p < 0,05 * * 2 * * 0 no risk factors smoking arterial Hypertension diabetes mellitus hyperlipidemia volume score above 100 Becker A, Knez A et al. Circulation 2004 (Suppl)

St. Francis Heart Study n= 4.903 asymptomatic individuals Arad et al. JACC 2005

Calcium Screening in ER-Department follow-up of 192 symptomatic patients (104 men, 88 women), age 53 ± 9 years follow-up period 50 ± 10 month (range 1 84 month) endpoints: hard cardiovascular events Georgiou et al. JACC 2001

Coronary calcifications in dependence of cardiovascular risk factors: 600 n = 142 n = 352 n = 598 n = 312 n = 397 * volume score 400 200 * = p < 0,05 * * 0 no risk factors smoking arterial hypertension diabetes mellitus hyperlipidemia Becker A, Knez A et al. Circulation 2004 (Suppl)